Ingelvac MycoFLEX® Ingelvac MycoFLEX® For the active immunisation of pigs from the age of three weeks to reduce lung lesions following infections with Mycoplasma hyopneumoniae.
Why is Diversity, Equity and Inclusion important to us? Why is Diversity, Equity and Inclusion important to us? Why is Diversity, Equity and Inclusion important to us?
Access to Healthcare Strategy Innovation Access to Healthcare Strategy Innovation Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Chronic Kidney Disease Chronic Kidney Disease Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.
2023 Moving towards a rabies-free Southeast Asia_Whitepaper.pdf 2023 Moving towards a rabies-free Southeast Asia_Whitepaper.pdf
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering Day France Flyer Save the date 2018 08 02.pdf Partnering Day France Flyer Save the date 2018 08 02.pdf
Praxbind® – the specific reversal agent to dabigatran.pdf Praxbind® – the specific reversal agent to dabigatran.pdf